Vernazza PL - Search Results

1

Prevalence of hepatitis C infection in Malawi and lack of association with sexually transmitted diseases.

Maida MJ, Daly CC, Hoffman I, Cohen MS, Kumwenda M, Vernazza PL. Maida MJ, et al. Among authors: vernazza pl. Eur J Epidemiol. 2000;16(12):1183-4. doi: 10.1023/a:1010920426795. Eur J Epidemiol. 2000. PMID: 11484810

2

Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group.

Cohen MS, Hoffman IF, Royce RA, Kazembe P, Dyer JR, Daly CC, Zimba D, Vernazza PL, Maida M, Fiscus SA, Eron JJ Jr. Cohen MS, et al. Among authors: vernazza pl. Lancet. 1997 Jun 28;349(9069):1868-73. doi: 10.1016/s0140-6736(97)02190-9. Lancet. 1997. PMID: 9217758

3

Association of CD4 cell depletion and elevated blood and seminal plasma human immunodeficiency virus type 1 (HIV-1) RNA concentrations with genital ulcer disease in HIV-1-infected men in Malawi.

Dyer JR, Eron JJ, Hoffman IF, Kazembe P, Vernazza PL, Nkata E, Costello Daly C, Fiscus SA, Cohen MS. Dyer JR, et al. Among authors: vernazza pl. J Infect Dis. 1998 Jan;177(1):224-7. doi: 10.1086/517359. J Infect Dis. 1998. PMID: 9419194

4

[HIV test and prevention].

Bickel A, Vernazza P. Bickel A, et al. Internist (Berl). 2012 Oct;53(10):1179-86. doi: 10.1007/s00108-011-2971-8. Internist (Berl). 2012. PMID: 22986541 German.

5

Detection of drug-resistant HIV minorities in clinical specimens and therapy failure.

Louvel S, Battegay M, Vernazza P, Bregenzer T, Klimkait T, Hamy F; Swiss HIV Cohort Study. Louvel S, et al. HIV Med. 2008 Mar;9(3):133-41. doi: 10.1111/j.1468-1293.2007.00529.x. Epub 2008 Jan 21. HIV Med. 2008. PMID: 18218003 Free article.

6

[HIV prevention in HIV-positive drug addicts. A methadone-supported model].

Oertle D, Edelmann R, Ostewalder J, Vernazza PL, Galeazzi RL. Oertle D, et al. Among authors: vernazza pl. Schweiz Med Wochenschr. 1993 Dec 4;123(48):2284-92. Schweiz Med Wochenschr. 1993. PMID: 8272803 German.

7

Uniform risk of clinical progression despite differences in utilization of highly active antiretroviral therapy: Swiss HIV Cohort Study.

Junghans C, Low N, Chan P, Witschi A, Vernazza P, Egger M. Junghans C, et al. AIDS. 1999 Dec 24;13(18):2547-54. doi: 10.1097/00002030-199912240-00008. AIDS. 1999. PMID: 10630524

8

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study.

Ledergerber B, Egger M, Opravil M, Telenti A, Hirschel B, Battegay M, Vernazza P, Sudre P, Flepp M, Furrer H, Francioli P, Weber R. Ledergerber B, et al. Lancet. 1999 Mar 13;353(9156):863-8. doi: 10.1016/s0140-6736(99)01122-8. Lancet. 1999. PMID: 10093977

9

HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load.

Phillips AN, Staszewski S, Weber R, Kirk O, Francioli P, Miller V, Vernazza P, Lundgren JD, Ledergerber B; Swiss HIV Cohort Study; Frakfurt HIV Clinic Cohort; EuroSIDA Study Group. Phillips AN, et al. JAMA. 2001 Nov 28;286(20):2560-7. doi: 10.1001/jama.286.20.2560. JAMA. 2001. PMID: 11722270

10

A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia.

Hirschel B, Lazzarin A, Chopard P, Opravil M, Furrer HJ, Rüttimann S, Vernazza P, Chave JP, Ancarani F, Gabriel V, et al. Hirschel B, et al. N Engl J Med. 1991 Apr 18;324(16):1079-83. doi: 10.1056/NEJM199104183241602. N Engl J Med. 1991. PMID: 2008181 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results